Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline (Q36804433)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 March 2010
edit
Language Label Description Also known as
English
Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline
scientific article published on 19 March 2010

    Statements

    Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline (English)
    0 references
    0 references
    M C Hosseinipour
    J J Kumwenda
    L B Brown
    D Mzinganjira
    B Mhango
    S Phiri
    J J van Oosterhout
    19 March 2010
    510-518

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit